Successful treatment of intraocular post‐transplant lymphoproliferative disorder with intravenous rituximab

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|62|1|169-172

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.1, 2015-01, pp. : 169-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Unique Case of Rituximab‐Related Posterior Reversible Encephalopathy Syndrome in a Heart Transplant Recipient With Posttransplant Lymphoproliferative Disorder

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 3, 2015-03 ,pp. : 823-826

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe PTLD after liver transplantation

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 3, 2015-03 ,pp. : 356-362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in the skin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 9, 2015-09 ,pp. : 936-937

John Wiley & Sons Inc

Access to resources Recommend Favorite

A retrospective analysis of post‐transplant lymphoproliferative disorder following liver transplantation

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 98-103

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia

By  

Acta Haematologica, Vol. 136, Iss. 3, 2016-08 ,pp. : 174-177

Karger

Access to resources Recommend Favorite